Pathogenic COL7A1 gene (C7) mutations are the primary cause of recessive dystrophic epidermolysis bullosa (RDEB), and restoring the normal expression of COL7A1 and producing type VII collagen is critical for treating RDEB. Here, COL7A1 is linked to recessive dystrophic epidermolysis bullosa inversa.